Edwards Lifesciences Corp. 13F holders
Of the 44 funds followed here, 11 reported a position in Edwards Lifesciences Corp. in a 13F for the quarter ended 30 June 2026. The largest: Geode Capital Management, 15.4 million shares worth $1.39 billion, 0.1% of its reported book. Sold out: Viking Global Investors.
| Fund | Shares | Value | Of its book | Change on the quarter | Status | Quarter ended | Filing |
|---|---|---|---|---|---|---|---|
| Geode Capital Management | 15,437,251 | $1.39 billion | 0.1% | +2,303,474 | added | 30 June 2026 | 13F |
| FMR LLC | 8,435,949 | $763.1 million | 0.0% | -6,067,821 | trimmed | 30 June 2026 | 13F |
| Norges Bank | 8,373,783 | $757.5 million | 0.1% | held | 30 June 2026 | 13F | |
| Citadel Advisors | 4,271,625 | $386.4 million | 0.0% | +3,597,594 | added | 30 June 2026 | 13F |
| Millennium Management | 3,767,595 | $340.8 million | 0.1% | +1,782,374 | added | 30 June 2026 | 13F |
| Point72 Asset Management | 1,780,520 | $161.1 million | 0.2% | -50,717 | trimmed | 30 June 2026 | 13F |
| Two Sigma Investments | 1,542,799 | $139.6 million | 0.1% | +466,164 | added | 30 June 2026 | 13F |
| Baillie Gifford | 1,208,945 | $109.4 million | 0.1% | +768,737 | added | 30 June 2026 | 13F |
| Alyeska | 812,860 | $73.5 million | 0.2% | -293,476 | trimmed | 30 June 2026 | 13F |
| Bridgewater Associates | 275,279 | $24.9 million | 0.1% | +103,356 | added | 30 June 2026 | 13F |
| Renaissance Technologies | 21,000 | $1.9 million | 0.0% | -8,000 | trimmed | 30 June 2026 | 13F |
| Viking Global Investors | 0 | $0 | 0.0% | -1,097,578 | exited | 30 June 2026 | 13F |
Value is what the fund reported. Change is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.
Schedule 13D and 13G filed on the name, last twelve months
| Filed | Schedule | Who | Holding | Of the class | Event date | Rule or purpose | Filing |
|---|---|---|---|---|---|---|---|
| 29 April 2026 | 13G | Vanguard Capital Management and 1 other | 43.5 million | 7.5% | 31 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 26 March 2026 | 13G/A | The Vanguard Group and 1 other | 0 | 0.0% | 13 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 17 October 2025 | 13G/A | BlackRock, Inc. and 1 other | 44.3 million | 7.5% | 30 September 2025 | passive, institutional (13d-1(b)) | EDGAR |
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder. Amendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short.
Fails to deliver
| Settlement date | Shares failed | Price | File |
|---|---|---|---|
| 28 August 2026 | 658 | $89.95 | SEC |
| 27 August 2026 | 1,971 | $90.78 | SEC |
| 24 August 2026 | 2,037 | $89.79 | SEC |
| 18 August 2026 | 1 | $90.81 | SEC |
| 11 August 2026 | 50,336 | $92.03 | SEC |
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period. Largest in the window: 50,336 on 11 August 2026. A fail is an operational fact about settlement, not a position.
Source
Each fund's 13F-HR on EDGAR, linked per row; positions matched to EW by CUSIP from the SEC's own fails-to-deliver files; Schedule 13D and 13G from the company's own filing index, each read to confirm the company is the issuer named.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.